nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.306	0.428	CbGbCtD
Daunorubicin—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.282	0.395	CbGbCtD
Daunorubicin—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.126	0.177	CbGbCtD
Daunorubicin—Rectal tenesmus—Riluzole—amyotrophic lateral sclerosis	0.00632	0.0379	CcSEcCtD
Daunorubicin—Dental caries—Riluzole—amyotrophic lateral sclerosis	0.00632	0.0379	CcSEcCtD
Daunorubicin—Pericarditis—Riluzole—amyotrophic lateral sclerosis	0.00545	0.0327	CcSEcCtD
Daunorubicin—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.00502	0.0301	CcSEcCtD
Daunorubicin—Bundle branch block—Riluzole—amyotrophic lateral sclerosis	0.00467	0.028	CcSEcCtD
Daunorubicin—NR5A1—hindbrain—amyotrophic lateral sclerosis	0.00437	0.111	CbGeAlD
Daunorubicin—Epirubicin—PLA2G4A—amyotrophic lateral sclerosis	0.00433	1	CrCbGaD
Daunorubicin—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00431	0.0258	CcSEcCtD
Daunorubicin—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.00415	0.0249	CcSEcCtD
Daunorubicin—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0036	0.0216	CcSEcCtD
Daunorubicin—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00346	0.0207	CcSEcCtD
Daunorubicin—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.00318	0.0191	CcSEcCtD
Daunorubicin—TOP2B—hindbrain—amyotrophic lateral sclerosis	0.00279	0.0709	CbGeAlD
Daunorubicin—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00261	0.0156	CcSEcCtD
Daunorubicin—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00259	0.0155	CcSEcCtD
Daunorubicin—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00257	0.0154	CcSEcCtD
Daunorubicin—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00254	0.0152	CcSEcCtD
Daunorubicin—NR5A1—brainstem—amyotrophic lateral sclerosis	0.00251	0.0639	CbGeAlD
Daunorubicin—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00249	0.0149	CcSEcCtD
Daunorubicin—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00241	0.0145	CcSEcCtD
Daunorubicin—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00236	0.0141	CcSEcCtD
Daunorubicin—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00233	0.014	CcSEcCtD
Daunorubicin—Melaena—Riluzole—amyotrophic lateral sclerosis	0.0023	0.0138	CcSEcCtD
Daunorubicin—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00207	0.0124	CcSEcCtD
Daunorubicin—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00204	0.0123	CcSEcCtD
Daunorubicin—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.002	0.012	CcSEcCtD
Daunorubicin—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.002	0.012	CcSEcCtD
Daunorubicin—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00196	0.0117	CcSEcCtD
Daunorubicin—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00191	0.0115	CcSEcCtD
Daunorubicin—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00189	0.0113	CcSEcCtD
Daunorubicin—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00182	0.0109	CcSEcCtD
Daunorubicin—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00182	0.0109	CcSEcCtD
Daunorubicin—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.0018	0.0108	CcSEcCtD
Daunorubicin—Thirst—Riluzole—amyotrophic lateral sclerosis	0.0018	0.0108	CcSEcCtD
Daunorubicin—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00177	0.0106	CcSEcCtD
Daunorubicin—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00175	0.0105	CcSEcCtD
Daunorubicin—TOP2B—embryo—amyotrophic lateral sclerosis	0.00174	0.0444	CbGeAlD
Daunorubicin—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0103	CcSEcCtD
Daunorubicin—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00168	0.0101	CcSEcCtD
Daunorubicin—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00975	CcSEcCtD
Daunorubicin—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00972	CcSEcCtD
Daunorubicin—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00965	CcSEcCtD
Daunorubicin—TOP2B—brainstem—amyotrophic lateral sclerosis	0.0016	0.0407	CbGeAlD
Daunorubicin—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00954	CcSEcCtD
Daunorubicin—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00908	CcSEcCtD
Daunorubicin—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00887	CcSEcCtD
Daunorubicin—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00864	CcSEcCtD
Daunorubicin—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00842	CcSEcCtD
Daunorubicin—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00829	CcSEcCtD
Daunorubicin—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00829	CcSEcCtD
Daunorubicin—Depression—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00788	CcSEcCtD
Daunorubicin—NR5A1—nervous system—amyotrophic lateral sclerosis	0.00131	0.0335	CbGeAlD
Daunorubicin—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00779	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00775	CcSEcCtD
Daunorubicin—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00775	CcSEcCtD
Daunorubicin—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00771	CcSEcCtD
Daunorubicin—NR5A1—central nervous system—amyotrophic lateral sclerosis	0.00126	0.0322	CbGeAlD
Daunorubicin—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00742	CcSEcCtD
Daunorubicin—NR5A1—cerebellum—amyotrophic lateral sclerosis	0.00124	0.0315	CbGeAlD
Daunorubicin—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00711	CcSEcCtD
Daunorubicin—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00706	CcSEcCtD
Daunorubicin—YWHAG—medulla oblongata—amyotrophic lateral sclerosis	0.00116	0.0294	CbGeAlD
Daunorubicin—TOP2B—medulla oblongata—amyotrophic lateral sclerosis	0.00111	0.0284	CbGeAlD
Daunorubicin—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00659	CcSEcCtD
Daunorubicin—Chills—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00637	CcSEcCtD
Daunorubicin—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00634	CcSEcCtD
Daunorubicin—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00627	CcSEcCtD
Daunorubicin—YWHAG—spinal cord—amyotrophic lateral sclerosis	0.00103	0.0262	CbGeAlD
Daunorubicin—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00605	CcSEcCtD
Daunorubicin—NR5A1—brain—amyotrophic lateral sclerosis	0.001	0.0256	CbGeAlD
Daunorubicin—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000996	0.00598	CcSEcCtD
Daunorubicin—TOP2B—spinal cord—amyotrophic lateral sclerosis	0.000993	0.0253	CbGeAlD
Daunorubicin—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000965	0.00579	CcSEcCtD
Daunorubicin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000956	0.00573	CcSEcCtD
Daunorubicin—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000952	0.00571	CcSEcCtD
Daunorubicin—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000947	0.00568	CcSEcCtD
Daunorubicin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000929	0.00557	CcSEcCtD
Daunorubicin—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000924	0.00554	CcSEcCtD
Daunorubicin—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000922	0.00553	CcSEcCtD
Daunorubicin—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00091	0.00546	CcSEcCtD
Daunorubicin—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000905	0.00543	CcSEcCtD
Daunorubicin—Cough—Riluzole—amyotrophic lateral sclerosis	0.000899	0.00539	CcSEcCtD
Daunorubicin—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000892	0.00535	CcSEcCtD
Daunorubicin—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000889	0.00533	CcSEcCtD
Daunorubicin—POR—medulla oblongata—amyotrophic lateral sclerosis	0.000878	0.0224	CbGeAlD
Daunorubicin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000877	0.00526	CcSEcCtD
Daunorubicin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000877	0.00526	CcSEcCtD
Daunorubicin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000877	0.00526	CcSEcCtD
Daunorubicin—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000874	0.00524	CcSEcCtD
Daunorubicin—YWHAG—nervous system—amyotrophic lateral sclerosis	0.000868	0.0221	CbGeAlD
Daunorubicin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000866	0.0052	CcSEcCtD
Daunorubicin—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000858	0.00514	CcSEcCtD
Daunorubicin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000848	0.00508	CcSEcCtD
Daunorubicin—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000841	0.00504	CcSEcCtD
Daunorubicin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000841	0.00504	CcSEcCtD
Daunorubicin—TOP2B—nervous system—amyotrophic lateral sclerosis	0.000836	0.0213	CbGeAlD
Daunorubicin—YWHAG—central nervous system—amyotrophic lateral sclerosis	0.000836	0.0213	CbGeAlD
Daunorubicin—Infection—Riluzole—amyotrophic lateral sclerosis	0.000835	0.00501	CcSEcCtD
Daunorubicin—Shock—Riluzole—amyotrophic lateral sclerosis	0.000827	0.00496	CcSEcCtD
Daunorubicin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000823	0.00494	CcSEcCtD
Daunorubicin—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00082	0.00492	CcSEcCtD
Daunorubicin—YWHAG—cerebellum—amyotrophic lateral sclerosis	0.000817	0.0208	CbGeAlD
Daunorubicin—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000813	0.00487	CcSEcCtD
Daunorubicin—TOP2B—central nervous system—amyotrophic lateral sclerosis	0.000805	0.0205	CbGeAlD
Daunorubicin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000801	0.00481	CcSEcCtD
Daunorubicin—TOP2B—cerebellum—amyotrophic lateral sclerosis	0.000787	0.02	CbGeAlD
Daunorubicin—POR—spinal cord—amyotrophic lateral sclerosis	0.000783	0.0199	CbGeAlD
Daunorubicin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000766	0.00459	CcSEcCtD
Daunorubicin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00076	0.00456	CcSEcCtD
Daunorubicin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000749	0.00449	CcSEcCtD
Daunorubicin—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000747	0.00448	CcSEcCtD
Daunorubicin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000731	0.00438	CcSEcCtD
Daunorubicin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000725	0.00435	CcSEcCtD
Daunorubicin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000719	0.00431	CcSEcCtD
Daunorubicin—Pain—Riluzole—amyotrophic lateral sclerosis	0.000719	0.00431	CcSEcCtD
Daunorubicin—ABCC10—medulla oblongata—amyotrophic lateral sclerosis	0.000697	0.0177	CbGeAlD
Daunorubicin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000693	0.00415	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000687	0.00412	CcSEcCtD
Daunorubicin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000668	0.00401	CcSEcCtD
Daunorubicin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000665	0.00399	CcSEcCtD
Daunorubicin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000665	0.00399	CcSEcCtD
Daunorubicin—YWHAG—brain—amyotrophic lateral sclerosis	0.000663	0.0169	CbGeAlD
Daunorubicin—TOP2B—brain—amyotrophic lateral sclerosis	0.000639	0.0163	CbGeAlD
Daunorubicin—ABCC10—spinal cord—amyotrophic lateral sclerosis	0.000621	0.0158	CbGeAlD
Daunorubicin—POR—cerebellum—amyotrophic lateral sclerosis	0.000621	0.0158	CbGeAlD
Daunorubicin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000619	0.00371	CcSEcCtD
Daunorubicin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000603	0.00362	CcSEcCtD
Daunorubicin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000595	0.00357	CcSEcCtD
Daunorubicin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000575	0.00345	CcSEcCtD
Daunorubicin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000556	0.00333	CcSEcCtD
Daunorubicin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000534	0.00321	CcSEcCtD
Daunorubicin—Rash—Riluzole—amyotrophic lateral sclerosis	0.00053	0.00318	CcSEcCtD
Daunorubicin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00053	0.00318	CcSEcCtD
Daunorubicin—Headache—Riluzole—amyotrophic lateral sclerosis	0.000527	0.00316	CcSEcCtD
Daunorubicin—POR—brain—amyotrophic lateral sclerosis	0.000504	0.0128	CbGeAlD
Daunorubicin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000499	0.00299	CcSEcCtD
Daunorubicin—ABCC10—cerebellum—amyotrophic lateral sclerosis	0.000493	0.0125	CbGeAlD
Daunorubicin—CYP1B1—nervous system—amyotrophic lateral sclerosis	0.000412	0.0105	CbGeAlD
Daunorubicin—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000408	0.0104	CbGeAlD
Daunorubicin—ABCC10—brain—amyotrophic lateral sclerosis	0.0004	0.0102	CbGeAlD
Daunorubicin—CYP1B1—central nervous system—amyotrophic lateral sclerosis	0.000396	0.0101	CbGeAlD
Daunorubicin—CYP1B1—cerebellum—amyotrophic lateral sclerosis	0.000387	0.00987	CbGeAlD
Daunorubicin—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.000364	0.00927	CbGeAlD
Daunorubicin—ABCC1—cerebellum—amyotrophic lateral sclerosis	0.000348	0.00888	CbGeAlD
Daunorubicin—ABCB1—embryo—amyotrophic lateral sclerosis	0.000315	0.00802	CbGeAlD
Daunorubicin—CYP1B1—brain—amyotrophic lateral sclerosis	0.000315	0.00801	CbGeAlD
Daunorubicin—CYP1A1—nervous system—amyotrophic lateral sclerosis	0.000291	0.00741	CbGeAlD
Daunorubicin—ABCG2—cerebellum—amyotrophic lateral sclerosis	0.000289	0.00735	CbGeAlD
Daunorubicin—ABCC1—brain—amyotrophic lateral sclerosis	0.000283	0.00721	CbGeAlD
Daunorubicin—CYP1A1—central nervous system—amyotrophic lateral sclerosis	0.00028	0.00714	CbGeAlD
Daunorubicin—ABCG2—brain—amyotrophic lateral sclerosis	0.000234	0.00597	CbGeAlD
Daunorubicin—CYP1A1—brain—amyotrophic lateral sclerosis	0.000222	0.00567	CbGeAlD
Daunorubicin—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000214	0.00544	CbGeAlD
Daunorubicin—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000206	0.00524	CbGeAlD
Daunorubicin—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000201	0.00512	CbGeAlD
Daunorubicin—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000179	0.00457	CbGeAlD
Daunorubicin—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000151	0.00385	CbGeAlD
Daunorubicin—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000146	0.00371	CbGeAlD
Daunorubicin—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000142	0.00362	CbGeAlD
Daunorubicin—ABCB1—brain—amyotrophic lateral sclerosis	0.000116	0.00294	CbGeAlD
Daunorubicin—SLC22A2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	9.78e-05	0.00128	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—TP53—amyotrophic lateral sclerosis	9.65e-05	0.00127	CbGpPWpGaD
Daunorubicin—CYP1B1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.65e-05	0.00127	CbGpPWpGaD
Daunorubicin—CYP1B1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.51e-05	0.00125	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.49e-05	0.00125	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	9.4e-05	0.00123	CbGpPWpGaD
Daunorubicin—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.35e-05	0.00123	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	9.35e-05	0.00123	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—VAPA—amyotrophic lateral sclerosis	9.3e-05	0.00122	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TPK1—amyotrophic lateral sclerosis	9.13e-05	0.0012	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	9.09e-05	0.00119	CbGpPWpGaD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	9.09e-05	0.00119	CbGpPWpGaD
Daunorubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—amyotrophic lateral sclerosis	8.91e-05	0.00117	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	8.84e-05	0.00116	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	8.69e-05	0.00114	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.65e-05	0.00114	CbGpPWpGaD
Daunorubicin—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	8.46e-05	0.00111	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	8.28e-05	0.00109	CbGpPWpGaD
Daunorubicin—CYP1A1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	8.27e-05	0.00109	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	8.17e-05	0.00107	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—FIG4—amyotrophic lateral sclerosis	8.13e-05	0.00107	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	8.12e-05	0.00107	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	8.06e-05	0.00106	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	7.97e-05	0.00105	CbGpPWpGaD
Daunorubicin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	7.71e-05	0.00101	CbGpPWpGaD
Daunorubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	7.66e-05	0.00101	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—TPK1—amyotrophic lateral sclerosis	7.64e-05	0.001	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—VAPB—amyotrophic lateral sclerosis	7.64e-05	0.001	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PLB1—amyotrophic lateral sclerosis	7.56e-05	0.000992	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—TPK1—amyotrophic lateral sclerosis	7.39e-05	0.00097	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—VAPB—amyotrophic lateral sclerosis	7.39e-05	0.00097	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—DAO—amyotrophic lateral sclerosis	7.35e-05	0.000965	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—VTA1—amyotrophic lateral sclerosis	7.3e-05	0.000958	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—MMP9—amyotrophic lateral sclerosis	7.21e-05	0.000946	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	7.18e-05	0.000943	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	7.13e-05	0.000935	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	7.06e-05	0.000927	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	7.01e-05	0.00092	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—VAPA—amyotrophic lateral sclerosis	6.99e-05	0.000918	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—GSR—amyotrophic lateral sclerosis	6.98e-05	0.000916	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	6.96e-05	0.000914	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	6.94e-05	0.000911	CbGpPWpGaD
Daunorubicin—YWHAG—Apoptosis—TP53—amyotrophic lateral sclerosis	6.9e-05	0.000906	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	6.89e-05	0.000905	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	6.86e-05	0.000901	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.86e-05	0.0009	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.86e-05	0.0009	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	6.85e-05	0.000899	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.78e-05	0.000889	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.78e-05	0.000889	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—VAPA—amyotrophic lateral sclerosis	6.76e-05	0.000887	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	6.72e-05	0.000883	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	6.72e-05	0.000883	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—VAPB—amyotrophic lateral sclerosis	6.66e-05	0.000874	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—TPK1—amyotrophic lateral sclerosis	6.66e-05	0.000874	CbGpPWpGaD
Daunorubicin—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	6.53e-05	0.000857	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	6.52e-05	0.000855	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.5e-05	0.000853	CbGpPWpGaD
Daunorubicin—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	6.47e-05	0.00085	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	6.47e-05	0.000849	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	6.45e-05	0.000847	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	6.37e-05	0.000836	CbGpPWpGaD
Daunorubicin—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.29e-05	0.000825	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.28e-05	0.000825	CbGpPWpGaD
Daunorubicin—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.2e-05	0.000814	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	6.15e-05	0.000807	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.11e-05	0.000802	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—FIG4—amyotrophic lateral sclerosis	6.11e-05	0.000802	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—VAPA—amyotrophic lateral sclerosis	6.09e-05	0.000799	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.04e-05	0.000793	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	5.96e-05	0.000783	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	5.96e-05	0.000783	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	5.96e-05	0.000782	CbGpPWpGaD
Daunorubicin—CYP1A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.94e-05	0.00078	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—FIG4—amyotrophic lateral sclerosis	5.91e-05	0.000776	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	5.9e-05	0.000775	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	5.9e-05	0.000775	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	5.88e-05	0.000772	CbGpPWpGaD
Daunorubicin—CYP1A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.86e-05	0.000769	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—CHAT—amyotrophic lateral sclerosis	5.73e-05	0.000752	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.72e-05	0.000751	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.66e-05	0.000743	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	5.64e-05	0.00074	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	5.6e-05	0.000735	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PLB1—amyotrophic lateral sclerosis	5.57e-05	0.000732	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	5.54e-05	0.000727	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CHMP2B—amyotrophic lateral sclerosis	5.53e-05	0.000726	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—DAO—amyotrophic lateral sclerosis	5.53e-05	0.000725	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	5.41e-05	0.00071	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	5.38e-05	0.000706	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—DAO—amyotrophic lateral sclerosis	5.34e-05	0.000701	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—FIG4—amyotrophic lateral sclerosis	5.32e-05	0.000698	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.31e-05	0.000698	CbGpPWpGaD
Daunorubicin—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	5.27e-05	0.000692	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.26e-05	0.00069	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	5.21e-05	0.000684	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—GSR—amyotrophic lateral sclerosis	5.14e-05	0.000675	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PLB1—amyotrophic lateral sclerosis	5e-05	0.000656	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	4.98e-05	0.000654	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	4.86e-05	0.000638	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	4.82e-05	0.000632	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	4.82e-05	0.000632	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—DAO—amyotrophic lateral sclerosis	4.81e-05	0.000632	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.68e-05	0.000615	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—VAPB—amyotrophic lateral sclerosis	4.55e-05	0.000598	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—TPK1—amyotrophic lateral sclerosis	4.55e-05	0.000598	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—VCP—amyotrophic lateral sclerosis	4.46e-05	0.000585	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	4.44e-05	0.000583	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	4.41e-05	0.000578	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	4.25e-05	0.000558	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.24e-05	0.000557	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—CHAT—amyotrophic lateral sclerosis	4.22e-05	0.000555	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	4.2e-05	0.000551	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PLB1—amyotrophic lateral sclerosis	4.19e-05	0.00055	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	4.17e-05	0.000547	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	4.16e-05	0.000547	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.1e-05	0.000538	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	4.09e-05	0.000536	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	4.05e-05	0.000532	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	4.01e-05	0.000526	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	3.92e-05	0.000515	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.87e-05	0.000508	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GSR—amyotrophic lateral sclerosis	3.86e-05	0.000507	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.85e-05	0.000506	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	3.85e-05	0.000506	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	3.79e-05	0.000498	CbGpPWpGaD
Daunorubicin—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.79e-05	0.000497	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GSR—amyotrophic lateral sclerosis	3.74e-05	0.000491	CbGpPWpGaD
Daunorubicin—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.74e-05	0.00049	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	3.68e-05	0.000484	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PLB1—amyotrophic lateral sclerosis	3.65e-05	0.000479	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.64e-05	0.000478	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	3.64e-05	0.000477	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	3.64e-05	0.000477	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	3.61e-05	0.000474	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.57e-05	0.000469	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.52e-05	0.000462	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	3.48e-05	0.000457	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.4e-05	0.000447	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	3.4e-05	0.000446	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GSR—amyotrophic lateral sclerosis	3.37e-05	0.000442	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	3.33e-05	0.000437	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	3.29e-05	0.000432	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.22e-05	0.000423	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.22e-05	0.000423	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CST3—amyotrophic lateral sclerosis	3.2e-05	0.00042	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.17e-05	0.000417	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.09e-05	0.000406	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.08e-05	0.000404	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.07e-05	0.000403	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.92e-05	0.000384	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.91e-05	0.000382	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	2.9e-05	0.000381	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	2.9e-05	0.000381	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.9e-05	0.00038	CbGpPWpGaD
Daunorubicin—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.88e-05	0.000378	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.87e-05	0.000377	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.83e-05	0.000371	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.8e-05	0.000368	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.79e-05	0.000367	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.76e-05	0.000363	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	2.73e-05	0.000358	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.71e-05	0.000355	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	2.65e-05	0.000348	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.64e-05	0.000347	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	2.64e-05	0.000347	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	2.63e-05	0.000345	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—TP53—amyotrophic lateral sclerosis	2.53e-05	0.000332	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.49e-05	0.000327	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.47e-05	0.000324	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	2.44e-05	0.00032	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—APOE—amyotrophic lateral sclerosis	2.33e-05	0.000306	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CASP9—amyotrophic lateral sclerosis	2.33e-05	0.000305	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.32e-05	0.000305	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	2.3e-05	0.000302	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.27e-05	0.000298	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	2.26e-05	0.000297	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	2.24e-05	0.000294	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	2.24e-05	0.000294	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	2.1e-05	0.000275	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	2.1e-05	0.000275	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.1e-05	0.000275	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.09e-05	0.000274	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	2.05e-05	0.000269	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	2e-05	0.000263	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.99e-05	0.000261	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—ERBB4—amyotrophic lateral sclerosis	1.99e-05	0.000261	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.98e-05	0.00026	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.92e-05	0.000252	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.9e-05	0.00025	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.89e-05	0.000248	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.84e-05	0.000241	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.79e-05	0.000235	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.78e-05	0.000234	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TP53—amyotrophic lateral sclerosis	1.77e-05	0.000232	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.72e-05	0.000226	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—APOE—amyotrophic lateral sclerosis	1.72e-05	0.000225	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.71e-05	0.000224	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.65e-05	0.000217	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.62e-05	0.000213	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.6e-05	0.000209	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.59e-05	0.000209	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.57e-05	0.000206	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—APOE—amyotrophic lateral sclerosis	1.54e-05	0.000202	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.52e-05	0.000199	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.51e-05	0.000198	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.5e-05	0.000197	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.49e-05	0.000195	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.47e-05	0.000193	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.38e-05	0.000181	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.36e-05	0.000179	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.35e-05	0.000177	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.34e-05	0.000175	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—APOE—amyotrophic lateral sclerosis	1.29e-05	0.000169	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—APOE—amyotrophic lateral sclerosis	1.25e-05	0.000164	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.23e-05	0.000161	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.21e-05	0.000158	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.18e-05	0.000155	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.18e-05	0.000154	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	1.13e-05	0.000149	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.13e-05	0.000149	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.12e-05	0.000147	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.1e-05	0.000144	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.08e-05	0.000141	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PTGS2—amyotrophic lateral sclerosis	1.06e-05	0.000138	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.02e-05	0.000133	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.88e-06	0.00013	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.34e-06	0.000123	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	9.3e-06	0.000122	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.84e-06	0.000116	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.55e-06	0.000112	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	8.13e-06	0.000107	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.11e-06	0.000107	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.78e-06	0.000102	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.69e-06	0.000101	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	7.68e-06	0.000101	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.54e-06	9.89e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.46e-06	9.79e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.48e-06	8.5e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	6.13e-06	8.05e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.95e-06	7.81e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.57e-06	7.31e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.26e-06	6.91e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	5e-06	6.56e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	4.9e-06	6.43e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.59e-06	6.03e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.2e-06	5.52e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	3.78e-06	4.96e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.36e-06	4.41e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.59e-06	3.4e-05	CbGpPWpGaD
